TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo

Benny Perlstein, Susan A. Finniss, Cathie Miller, Hana Okhrimenko, Gila Kazimirsky, Simona Cazacu, Hae Kyung Lee, Nancy Lemke, Shlomit Brodie, Felix Umansky, Sandra A. Rempel, Mark Rosenblum, Tom Mikklesen, Shlomo Margel, Chaya Brodie

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

Glioblastomas (GBM) are characterized by resistance to chemotherapy and radiotherapy, and therefore, alternative therapeutic approaches are needed. TRAIL induces apoptosis in cancer but not in normal cells and is considered to be a promising anti-tumor agent. However, its short in vivo half-life and lack of efficient administration modes are serious impediments to its therapeutic efficacy. Nanoparticles (NP) have been used as effective delivery tools for various anticancer drugs. TRAIL was conjugated to magnetic ferric oxide NP by binding the TRAIL primary amino groups to activated double bonds on the surface of the NP. The effect of NP-TRAIL was examined on the apoptosis of glioma cells and self-renewal of glioma stem cells (GSCs). In addition, the ability of the NP-TRAIL to track U251 cell-derived glioma xenografts and to affect cell apoptosis, tumor volume, and survival among xenografted rats was also examined. Conjugation of TRAIL to NP increased its apoptotic activity against different human glioma cells and GSCs, as compared with free recombinant TRAIL. Combined treatment with NP-TRAIL and γ-radiation or bortezomib sensitized TRAIL-resistant GSCs to NP-TRAIL. Using rhodamine-labeled NP and U251 glioma cell-derived xenografts, we demonstrated that the NP-TRAIL were found in the tumor site and induced a significant increase in glioma cell apoptosis, a decrease in tumor volume, and increased animal survival. In summary, conjugation of TRAIL to NP increased its apoptotic activity both in vitro and in vivo. Therefore, NP-TRAIL represents a targeted anticancer agent with more efficient action for the treatment of GBM and the eradication of GSCs.

Original languageEnglish
Pages (from-to)29-40
Number of pages12
JournalNeuro-Oncology
Volume15
Issue number1
DOIs
StatePublished - Jan 2013

Keywords

  • TRAIL
  • apoptosis
  • glioblastoma
  • iron oxide
  • nanoparticles

Fingerprint

Dive into the research topics of 'TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo'. Together they form a unique fingerprint.

Cite this